-
April 4, 2023 Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBSTryp completes their Phase 2a psilocybin for IBS clinical trial training for psychotherapists at Massachusetts...
-
October 13, 2022 Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS,...
-
October 6, 2022 Math Over Myth: Weekly Psychedelic Stocks News RoundupGet the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin...
